58 related articles for article (PubMed ID: 27895750)
1. Expression of Circulating MicroRNA-141 in Epithelial Ovarian Cancer.
Fitriawan AS; Kartika AI; Chasanah SN; Aryandono T; Haryana SM
Malays J Med Sci; 2020 Dec; 27(6):27-38. PubMed ID: 33447132
[TBL] [Abstract][Full Text] [Related]
2. Extracellular Vesicles-ceRNAs as Ovarian Cancer Biomarkers: Looking into circRNA-miRNA-mRNA Code.
Cammarata G; Barraco N; Giusti I; Gristina V; Dolo V; Taverna S
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884464
[TBL] [Abstract][Full Text] [Related]
3. ROS and miRNA Dysregulation in Ovarian Cancer Development, Angiogenesis and Therapeutic Resistance.
Stieg DC; Wang Y; Liu LZ; Jiang BH
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743145
[TBL] [Abstract][Full Text] [Related]
4. Downregulated circular RNA hsa_circ_0005797 inhibits endometrial cancer by modulating microRNA-298/Catenin delta 1 signaling.
Liu Y; Yuan H; He T
Bioengineered; 2022 Mar; 13(3):4634-4645. PubMed ID: 34852711
[TBL] [Abstract][Full Text] [Related]
5. CYP27B1 Downregulation: A New Molecular Mechanism Regulating EZH2 in Ovarian Cancer Tumorigenicity.
Huo X; Sun H; Qian Q; Ma X; Peng P; Yu M; Zhang Y; Yang J; Cao D; Gui T; Shen K
Front Cell Dev Biol; 2020; 8():561804. PubMed ID: 33163485
[TBL] [Abstract][Full Text] [Related]
6. Effects of CDK6 regulated by miR-298 on proliferation and apoptosis of thyroid cancer cells.
Li X; Liu C; Zhao X; Wang R; Gu N; Shen H; Li X; Wang L; Li C
Oncol Lett; 2020 Apr; 19(4):2909-2915. PubMed ID: 32218846
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-153 regulated AKT1 expression and suppressed cell proliferation of epithelial ovarian cancer cells.
Li W; Wang M; Meng B; Yu J; Chen Q; Li H; Liu Y
Int J Clin Exp Pathol; 2017; 10(7):7417-7426. PubMed ID: 31966584
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-298 reduces levels of human amyloid-β precursor protein (APP), β-site APP-converting enzyme 1 (BACE1) and specific tau protein moieties.
Chopra N; Wang R; Maloney B; Nho K; Beck JS; Pourshafie N; Niculescu A; Saykin AJ; Rinaldi C; Counts SE; Lahiri DK
Mol Psychiatry; 2021 Oct; 26(10):5636-5657. PubMed ID: 31942037
[TBL] [Abstract][Full Text] [Related]
9. Circulating microRNAs as novel potential diagnostic biomarkers for ovarian cancer: a systematic review and updated meta-analysis.
Wang X; Kong D; Wang C; Ding X; Zhang L; Zhao M; Chen J; Xu X; Hu X; Yang J; Gao S
J Ovarian Res; 2019 Mar; 12(1):24. PubMed ID: 30898156
[TBL] [Abstract][Full Text] [Related]
10. LncRNA GAS6-AS2 promotes bladder cancer proliferation and metastasis via GAS6-AS2/miR-298/CDK9 axis.
Rui X; Wang L; Pan H; Gu T; Shao S; Leng J
J Cell Mol Med; 2019 Feb; 23(2):865-876. PubMed ID: 30394665
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic Crosstalk between the Tumor Microenvironment and Ovarian Cancer Cells: A Therapeutic Road Less Traveled.
Klymenko Y; Nephew KP
Cancers (Basel); 2018 Aug; 10(9):. PubMed ID: 30200265
[TBL] [Abstract][Full Text] [Related]
12. LINC01287/miR-298/STAT3 feedback loop regulates growth and the epithelial-to-mesenchymal transition phenotype in hepatocellular carcinoma cells.
Mo Y; He L; Lai Z; Wan Z; Chen Q; Pan S; Li L; Li D; Huang J; Xue F; Che S
J Exp Clin Cancer Res; 2018 Jul; 37(1):149. PubMed ID: 30001751
[TBL] [Abstract][Full Text] [Related]
13. Histone Methyltransferase EZH2: A Therapeutic Target for Ovarian Cancer.
Jones BA; Varambally S; Arend RC
Mol Cancer Ther; 2018 Mar; 17(3):591-602. PubMed ID: 29726819
[TBL] [Abstract][Full Text] [Related]
14. miR-205 regulates the proliferation and invasion of ovarian cancer cells via suppressing PTEN/SMAD4 expression.
Chu P; Liang A; Jiang A; Zong L
Oncol Lett; 2018 May; 15(5):7571-7578. PubMed ID: 29725462
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatics analysis of RNA sequencing data reveals multiple key genes in uterine corpus endometrial carcinoma.
Shen L; Liu M; Liu W; Cui J; Li C
Oncol Lett; 2018 Jan; 15(1):205-212. PubMed ID: 29387216
[TBL] [Abstract][Full Text] [Related]
16. EZH2 in Cancer Progression and Potential Application in Cancer Therapy: A Friend or Foe?
Yan KS; Lin CY; Liao TW; Peng CM; Lee SC; Liu YJ; Chan WP; Chou RH
Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28561778
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-298 inhibits malignant phenotypes of epithelial ovarian cancer by regulating the expression of EZH2.
Zhou F; Chen J; Wang H
Oncol Lett; 2016 Nov; 12(5):3926-3932. PubMed ID: 27895750
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-130b functions as a tumor suppressor by regulating RUNX3 in epithelial ovarian cancer.
Paudel D; Zhou W; Ouyang Y; Dong S; Huang Q; Giri R; Wang J; Tong X
Gene; 2016 Jul; 586(1):48-55. PubMed ID: 27048832
[TBL] [Abstract][Full Text] [Related]
19. MiR-205 promotes motility of ovarian cancer cells via targeting ZEB1.
Niu K; Shen W; Zhang Y; Zhao Y; Lu Y
Gene; 2015 Dec; 574(2):330-6. PubMed ID: 26275944
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]